0.6855

9.86% -0.075

Abpro Holdings Inc (ABP)

Overview News Price History Discussions Forecast

Abpro Holdings Inc stock is traded at $0.6855, with a volume of 64,292. It is down -9.86% in the last 24 hours and down -46.86% over the past month. Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.

Previous Close:

$0.7605

Open:

$0.76

24h Volume:

64,292

Relative Volume:

0.09

Market Cap:

$35.62M

Revenue:

Net Income/Loss:

$-8.09M

P/E Ratio:

-4.2367

EPS:

-0.1618

Net Cash Flow:

$-8.31M

1W Performance:

-32.13%

1M Performance:

-46.86%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$0.6801

$0.77

1-Week Range:

$0.6801

$1.08

52-Week Range:

$0.6801

$5.13

Abpro Holdings Inc Stock (ABP) Company Profile

Name

Abpro Holdings Inc

Sector

Healthcare (1167)

Industry

Biotechnology (674)

Phone

248-890-7200

Address

6 ST JOHNS LANE, FLOOR 5, NEW YORK

Employee

Twitter

Next Earnings Date

Latest SEC Filings

ABP's Discussions on Twitter

Compare ABP with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ABP Abpro Holdings Inc	0.6855	35.62M	0	-8.09M	-8.31M	-0.1618
VRTX Vertex Pharmaceuticals Inc	480.35	123.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	723.47	79.09B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	624.94	37.97B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.20	31.74B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	259.70	27.71B	3.32B	-860.46M	-1.04B	-8.32

Abpro Holdings Inc Stock (ABP) Latest News

Feb 25, 2025

Abpro (NASDAQ:ABP) Now Covered by Analysts at Maxim Group - Defense World

Feb 25, 2025

Feb 24, 2025

Maxim Group Initiates Coverage of Abpro Holdings (ABP) with Buy Recommendation - Nasdaq

Feb 24, 2025

Feb 21, 2025

Abpro Holdings Highlights Strategic Partnerships in Biotech - TipRanks

Feb 21, 2025

Jan 14, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Jan 14, 2025

Dec 30, 2024

Stock market news: Abpro Holdings -52.75%, Traws Pharma -42.47% among biggest losers during mid day trading - Business Upturn

Dec 30, 2024

Stock market news: Nxu surged by 276.55% while Abpro Holdings climbed by 136.32% during mid day trading - Business Upturn

Dec 30, 2024

Stock market today: Abpro Holdings -42.09%, Traws Pharma -39.26% among biggest losers in early trading - Business Upturn

Dec 30, 2024

Dec 20, 2024

Vertex Pharmaceuticals (VRTX) Stock Surges Amid Mixed Analyst Ra - GuruFocus.com

Dec 20, 2024

Dec 13, 2024

Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing - The Manila Times

Dec 13, 2024

Dec 12, 2024

Abpro Holdings Completes Merger and Raises $10 Million - Nasdaq

Dec 12, 2024

Atlantic Coastal Acquisition Corp. II Dismisses Independent Registered Public Accounting Firm - Defense World

Dec 12, 2024

Dec 10, 2024

Abpro Holdings engages new accounting firm By Investing.com - Investing.com Canada

Dec 10, 2024

Abpro Holdings announces key post-merger developments By Investing.com - Investing.com Nigeria

Nov 26, 2024